Evidence map›Paper›PMID 24143878›Full record

ArticleBMC psychiatry2013

Dysregulation of leukocyte gene expression in women with medication-refractory depression versus healthy non-depressed controls.

Eli Iacob, Kathleen C Light, Scott C Tadler, Howard R Weeks, Andrea T White, Ronald W Hughen, Timothy A Vanhaitsma, Lowry Bushnell, Alan R Light

Open access · goldAbstract read
In one paragraph

Article in BMC psychiatry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics.Progress in neuro-psychopharmacology & biological psychiatry · 2015
    Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Biomarkers of Post-COVID Depression.Journal of clinical medicine · 2021
    Review
  8. Review
  9. Article
  10. Article
  11. Peripheral Markers of Depression.Journal of clinical medicine · 2020
    Review
  12. Article
  13. Effects of intranasal administration of the peptide antagonist of type I vaniloid receptor (TRPV1) in the rodent central nervous system.Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2016
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Eli IacobDepartment of Anesthesiology, University of Utah Health Sciences Center, Salt Lake City, UT, USA. eli.iacob@gmail.com.
Kathleen C Light
Scott C Tadler
Howard R Weeks
Andrea T White
Ronald W Hughen
Timothy A Vanhaitsma
Lowry Bushnell
Alan R Light
University of Utah · US

Funding

POST-EXERCISE ION CHANNEL GENE EXPRESSION BIOMARKERS IN CFSR01AR060336 · NIAMS · UNIVERSITY OF UTAH · PI LIGHT, KATHLEEN C · 2011 to 2013
$991k
NIAMS NIH HHS AR060336
6 · The paper itself

Abstract

backgroundDepressive Disorders (DD) are a great financial and social burden. Females display 70% higher rate of depression than males and more than 30% of these patients do not respond to conventional medications. Thus medication-refractory female patients are a large, under-served, group where new biological targets for intervention are greatly needed.

methodsWe used real-time quantitative polymerase chain reaction (qPCR) to evaluate mRNA gene expression from peripheral blood leukocytes for 27 genes, including immune, HPA-axis, ion channels, and growth and transcription factors. Our sample included 23 females with medication refractory DD: 13 with major depressive disorder (MDD), 10 with bipolar disorder (BPD). Our comparison group was 19 healthy, non-depressed female controls. We examined differences in mRNA expression in DD vs. controls, in MDD vs. BPD, and in patients with greater vs. lesser depression severity.

resultsDD patients showed increased expression for IL-10, IL-6, OXTR, P2RX7, P2RY1, and TRPV1. BPD patients showed increased APP, CREB1, NFKB1, NR3C1, and SPARC and decreased TNF expression. Depression severity was related to increased IL-10, P2RY1, P2RX1, and TRPV4 expression.

conclusionsThese results support prior findings of dysregulation in immune genes, and provide preliminary evidence of dysregulation in purinergic and other ion channels in females with medication-refractory depression, and in transcription and growth factors in those with BPD. If replicated in future research examining protein levels as well as mRNA, these pathways could potentially be used to explore biological mechanisms of depression and to develop new drug targets.

Indexed as

Gene Expression RegulationAdultBipolar DisorderCytokinesDepressive Disorder, Treatment-ResistantFemaleHumansLeukocytesMajor Depressive DisorderMaleMiddle AgedSeverity of Illness IndexCytokines

Identifiers

PMID24143878
PMCPMC4015603
OpenAlexW2123308453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.